On application of constitutional descriptors for merging of quinoxaline data sets using linear statistical methods

Chemical Biology and Drug Design

Volumn 72, Issue 2, 2008, Pages 155-162

  Ghosh, Payel ^a   Vracko, Marjan ^b   Chattopadhyay, Asis Kumar ^c   Bagchi, Manish C ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^c UNIVERSITY OF CALCUTTA   (India)

Author keywords

Partial least squares; Principal component analysis; Quantitative structure activity relationship; Quinoxaline compounds; Theoretical molecular descriptors

Indexed keywords

3 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE DERIVATIVE; QUINOXALINE; QUINOXALINE 2 CARBOXYLATE 1,4 DIOXIDE DERIVATIVE; QUINOXALINE DERIVATIVE; TUBERCULOSTATIC AGENT;

ARTICLE; CHEMICAL STRUCTURE; CONSTITUTIONAL DESCRIPTOR; DATA ANALYSIS; DRUG STRUCTURE; LINEAR SYSTEM; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANTIBIOTICS, ANTITUBERCULAR; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; QUINOXALINES;

EID: 47949090484     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00686.x     Document Type: Article

References (18)

1. Lubasch A., Erbes R., Munch H., Lode H. (2001) Sparfloxacin in treatment of drug resistant tuberculosis and intolerance of first line therapy. Eur Respir J 17 : 641 646.
2. Lednicer D. (1999) The Organic Chemistry of Drug Synthesis, vol. 6. New York : Wiley p. 159.
3. Cheeseman G., Cookson R., Weissberger E.C. (editors 1979) The Chemisty of Heterocyclic Compounds, vol. 35. New York : John Wiley and Sons p. 1 27.
4. Porter A.E., Katrizky A.R., Rees C.W. (editors 1984) Comprehensive Heterocyclic Chemistry, vol. 3. New York : Pergamon Press p. 195.
5. Carta A., Paglietti G., Nikookar M., Sanna P., Sechi L., Zanetti S. (2002) Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity. Eur J Med Chem 37 : 355 366.
6. Jaso A., Zarranz B., Aldana I., Monge A. (2005) Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-mycobacterium tuberculosis agents. J Med Chem 48 : 2019 2025.
7. el-Hawash S.A., Habib N.S., Fanaki N.H. (1999) Quinoxaline derivatives. Part II: synthesis and antimicrobial testing of 1,2,4- triazolo[4,3-a] quinoxaline 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines. Pharmazie 54 : 808 813.
8. Badran M.M., Abouzid K.A., Hussein M.H. (2003) Synthesis of certain substituted quinoxalines as antimicrobial agents (Part II). Arch Pharmacal Res 26 : 107 113.
9. Schoonjans V., Taylor N., Hadson B.D., Massart D.L. (2002) Characterization of the similarity of chemical compounds using electrospray ionization mass spectrometry and multivariate exploratory techniques. J Pharm Biomed Anal 28 : 537 548.
10. Hemmateenejad B., Safarpour M.A., Miri R., Taghavi F. (2004) Application of ab initio theory to QSAR study of 1, 4-dihydropyridine-based calcium channel blockers using GA-MLR and PC-GA-ANN procedures. J Comput Chem 25 : 1495 1503.
11. Khayamian T., Ensafi A.A., Hemmateenejad B. (1999) Simultaneous determination of cobalt, nickel and copper using partial least squares based on singular value decomposition. Talanta 49 : 587 596.
12. Hemmateenejad B., Miri R., Jafarpour M., Tabarzad M., Foroumadi A. (2005) Multiple linear regression and principal component analysis-based prediction of the anti-tuberculosis activity of some 2-aryl-1,3,4-thiadiazole derivatives. QSAR Comb Sci 25 : 56 66.
13. Wold S. (1995) PLS for multivariate linear modeling. in : van de Waterbeemd H. editor. Chemometric Methods in Molecular Design. Weinheim : VCH p. 195 218.
14. Kulkarni S.S., Kulkarni V.M. (1999) Three-dimensional quantitative structure-activity relationship of interleukin 1-β converting enzyme inhibitors: a comparative molecular field analysis study. J Med Chem 42 : 373 380.
15. Leonard J.T., Roy K. (2008) Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Eur J Med Chem 43 : 81 92.
16. Hawkins D.M., Basak S.C., Mills D. (2003) Assessing model fit by cross-validation. J Chem Inf Comput Sci 43 : 579 586.
17. Bagchi M.C., Mills D., Basak S.C. (2007) Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortiutum and M. smegmatis using theoretical molecular descriptors. J Mol Model 13 : 111 120.
18. Hattotuwagama C.K., Doytchinova I.A., Flower D.R. (2005) In silico prediction of peptide binding affinity to class I mouse major histocompatibility complexes: a comparative molecular similarity index analysis (CoMSIA) study. J Chem Inf Model 45 : 1415 1423.